Mark Giganti
机构: Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health
每年引用次数
引用次数
引用: 1,747
H-指数: 23
I10-指数 : 39
出版物: 70
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
Gabriela Carriquiry , Valeria Fink , John Robert Koethe , Mark Joseph Giganti
Journal of the International AIDS Society 18 ( 1) 20016 -20016
32
2015
2018
Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study
J. S. Stringer , A. J. Mwango , M. J. Giganti , L. Mulenga
International Journal of Epidemiology 41 ( 2) 448 -459
12
2012
Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge.
Y. Caro-Vega , P. F. Belaunzarán-Zamudio , B. Crabtree-Ramírez , B. E. Shepherd
Epidemiology and Infection 146 ( 10) 1308 -1311
6
2018
Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia
James Kahn , E Marseille , MJ Giganti , A Mwango
PLoS ONE 7 ( 12) e51993
42
2012
Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
Mark J Giganti , Mark J Abzug , Grace Montepiedra , Michael J Boivin
AIDS
2021
Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
Marcelo J Wolff , Claudia P Cortes , Fernando A Mejìa , Denis Padgett
International Journal of Std & Aids 29 ( 1) 4 -12
6
2018
Interaction between climatic, environmental, and demographic factors on cholera outbreaks in Kenya.
James D Stoltzfus , Jane Y Carter , Muge Akpinar-Elci , Martin Matu
Infectious Diseases of Poverty 3 ( 1) 37 -37
12
2014
Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting
John R Koethe , Elliot Marseille , Mark J Giganti , Benjamin H Chi
Cost Effectiveness and Resource Allocation 12 ( 1) 10 -10
7
2014
Multiple-Imputation Variance Estimation in Studies With Missing or Misclassified Inclusion Criteria.
Mark J Giganti , Bryan E Shepherd
American Journal of Epidemiology 189 ( 12) 1628 -1632
2020
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.
April C Pettit , Mark J Giganti , Suzanne M Ingle , Margaret T May
Journal of the International AIDS Society 21 ( 1)
18
2018
Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia
John R Koethe , Mohammed I Limbada , Mark J Giganti , Christopher K Nyirenda
AIDS 24 ( 13) 2117 -2121
29
2010
Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia
John R Koethe , Anna Lukusa , Mark J Giganti , Benjamin H Chi
Journal of Acquired Immune Deficiency Syndromes 53 ( 4) 507 -513
86
2010
Predictors of CD4 Eligibility for Antiretroviral Therapy Initiation Among HIV-Infected Pregnant Women in Lusaka, Zambia
Katherine C Liu , Jessica Mulindwa , Mark J Giganti , Nande B Putta
Journal of Acquired Immune Deficiency Syndromes 57 ( 5)
6
2011
Optimal time on HAART for prevention of mother-to-child transmission of HIV.
Carla J Chibwesha , Mark J Giganti , Nande Putta , Namwinga Chintu
Journal of Acquired Immune Deficiency Syndromes 58 ( 2) 224 -228
57
2011
Safety and efficacy of combined tixagevimab and cilgavimab administered intramuscularly or intravenously in nonhospitalized patients with COVID-19: 2 randomized clinical trials
Rachel A Bender Ignacio , Kara W Chew , Carlee Moser , Judith S Currier
JAMA Network Open 6 ( 4) e2310039 -e2310039
5
2023
Variant-Specific Viral Kinetics in Acute COVID-19
Ruy M Ribeiro , Manish C Choudhary , Rinki Deo , Mark J Giganti
The Journal of Infectious Diseases 228 ( Supplement_2) S136 -S143
1
2023
Health outcomes among HIV‐positive Latinos initiating antiretroviral therapy in North America versus Central and South America
Carina Cesar , John R Koethe , Mark J Giganti , Peter Rebeiro
African Journal of Reproduction and Gynaecological Endoscopy 19 ( 1)
12
2016
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering , Kara W Chew , Mark J Giganti , Carlee Moser
Annals of Internal Medicine 176 ( 5) 658 -666
15
2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo , Kara W Chew , Carlee Moser , David Alain Wohl
The Journal of infectious diseases 228 ( 2) 133 -142
7
2023